Protective Effects of Erythropoietin in Cardiac Ischemia
Authors:
- Regien G. SchoemakerRSRegien G. Schoemaker
- Peter van der MeerPMPeter van der Meer
- Adriaan A. VoorsAVAdriaan A. Voors
- Dirk J. van VeldhuisenDVDirk J. van Veldhuisen
- Wiek H. van GilstWGWiek H. van Gilst
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety StudyCardiovascular Drugs and Therapy, 2006
- Levels of Hematopoiesis Inhibitor N -Acetyl-Seryl-Aspartyl-Lysyl-Proline Partially Explain the Occurrence of Anemia in Heart FailureCirculation, 2005
- Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failureEuropean Heart Journal, 2005
- Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney diseaseAmerican Heart Journal, 2005
- Erythropoietin Just Before Reperfusion Reduces Both Lethal Arrhythmias and Infarct Size via the Phosphatidylinositol-3 Kinase-Dependent Pathway in Canine HeartsCardiovascular Drugs and Therapy, 2005
- EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancerEuropean Journal of Cancer, 2004
- Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivoKidney International, 2004
- Low-Dose Therapy With the Long-Acting Erythropoietin Analogue Darbepoetin Alpha Persistently Activates Endothelial Akt and Attenuates Progressive Organ FailureCirculation, 2004
- Erythropoietin regulates endothelial progenitor cellsBlood, 2004
- Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion InjuryCirculation, 2003